Uncovering Novel Solutions
At PsychoGenics, our forward-leaning approach in preclinical CNS research is anchored in both traditional and innovative methods. This dual approach, backed by experience, enables identification of effects in our animal models, offering a comprehensive evaluation of your compound’s efficacy in the target rare disease.
